Harrow Expands VEVYE Access for All Program to ImprimisRx’s Klarity-C Patients
April 10, 2025
Existing Klarity-C Patients to Have Access to VEVYE for $59 Per Bottle Harrow, a leading North American eyecare pharmaceutical company, announced an expansion of its VEVYE Access
